Quick Answer
Sanara MedTech Inc. reported Diluted EPS of $4.36 per share (loss) for fiscal year 2025.
Sanara MedTech Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.36 | -282.5% |
| 2024 | -$1.14 | -119.2% |
| 2023 | -$0.52 | +48.0% |
| 2022 | -$1.00 | -31.6% |
| 2020 | -$0.76 | +42.4% |
| 2019 | -$1.32 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | +100.0% |
| 2016 | -$0.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.40 | -900.0% | -1378.3% |
| June 30, 2025 | -$0.23 | +43.9% | +43.9% |
| March 31, 2025 | -$0.41 | -95.2% | -20.6% |
| September 30, 2024 | -$0.34 | -161.5% | +17.1% |
| June 30, 2024 | -$0.41 | -86.4% | -95.2% |
| March 31, 2024 | -$0.21 | -50.0% | -61.5% |
| September 30, 2023 | -$0.13 | +27.8% | +40.9% |
| June 30, 2023 | -$0.22 | -344.4% | -57.1% |
- Sanara MedTech Inc. showed a decrease of -282.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2025 period, Sanara MedTech Inc.’s diluted eps has declined by 43500.0% (from $0.01 per share (loss) to $4.36 per share (loss)).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: